Koyfin Home > Directory > Health Care > Amneal Pharmaceuticals Inc > Net Income

Amneal Pharmaceuticals Inc Net Income Chart (AMRX)

Amneal Pharmaceuticals Inc annual/quarterly Net Income from 2016 to 2018. Net income is calculated as sales less cost of goods sold, selling, general and administrative expenses, operating expenses, depreciation, interest, taxes and other expenses. This number appears on a company's income statement and is an important measure of how profitable the company is.
  • Amneal Pharmaceuticals Inc Net Income for the quarter ending December 12, 2018 was $-9m a 687.76% decrease of -60m year over year
  • Amneal Pharmaceuticals Inc Net Income for the last 12 months ending December 12, 2018 was $-170m a 204.48% decrease of -347m year over year
  • Amneal Pharmaceuticals Inc Annual Net Income for 2018 was $-170m a 198.78% decrease of -337m from 2017
  • Amneal Pharmaceuticals Inc Annual Net Income for 2017 was $168m a -23.70% decrease of -40m from 2016
  • Amneal Pharmaceuticals Inc Annual Net Income for 2016 was $207m a 18.29% increase of 38m from 2015
Other Income Statement Metrics:
  • Amneal Pharmaceuticals Inc EBITDA for the quarter ending December 12, 2018 was $109m a 21.60% increase of 24m year over year
  • Amneal Pharmaceuticals Inc Total Revenue for the quarter ending December 12, 2018 was $498m a 44.69% increase of 222m year over year
View Chart On Koyfin

Quarterly AMRX Net Income Data

12/2018$-9m
09/2018$7m
06/2018$-219m
03/2018$52m
12/2017$62m
09/2017$27m
06/2017$37m
03/2017$42m
12/2016$54m

Annual AMRX Net Income Data

2018$-170m
2017$168m
2016$207m
2015$169m
2014$177m